PMC:7600245 / 3457-3654
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T20 | 96-104 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T9 | 57-60 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T15 | 45-56 | Chemical | denotes | favipiravir | http://purl.obolibrary.org/obo/CHEBI_134722 |
| T16 | 163-176 | Chemical | denotes | dexamethasone | http://purl.obolibrary.org/obo/CHEBI_41879 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T26 | 32-152 | Sentence | denotes | Furthermore, favipiravir has been approved for the treatment of COVID-19 in the hospital settings in few countries [10]. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 68 | 45-56 | Chemical | denotes | favipiravir | MESH:C462182 |
| 69 | 163-176 | Chemical | denotes | dexamethasone | MESH:D003907 |
| 72 | 96-104 | Disease | denotes | COVID-19 | MESH:C000657245 |